BUILDING DEEP KNOWLEDGE OF COMPLEX HUMAN BIOLOGY TO DRIVE THE NEXT GENERATION OF BREAKTHROUGH THERAPIES

We uniquely bring together supercomputing power, our proven causal AI reverse-engineering engine, and our collaborators’ massive patient multiomics and outcome datasets to build Gemini Digital Twins, in silico models of human disease that drives successful knowledge-based discoveries across pharmaceutical R&D.

GENERATING NOVEL AND PRECISE UNDERSTANDINGS OF HUMAN DISEASE TO DRIVE PHARMACEUTICAL DISCOVERY AND DEVELOPMENT

Understanding the molecular interactions that cause diseases reveals a set of novel potential intervention points to discover new and highly targeted drugs in partnership with pharma companies that can prevent further development or even reverse the disease process.

NEW BIOLOGICAL KNOWLEDGE DRIVES FIRST-IN-CLASS AND BEST-IN-CLASS THERAPEUTICS

Aitia’s causal AI knowledge discovery engine is leading to differentiated and novel partnered programs across multiple diseases with high unmet medical need.

Our Team

We are a world-class team of AI pioneers, R&D veterans, and biotech company builders backed by top-tier healthcare and strategic pharma investors leaders working toward our shared mission.

WE ARE TRUE COLLABORATORS IN SHARING OUR KNOWLEDGE TO TRANSFORM DRUG DISCOVERY AND DEVELOPMENT

We bring our technology, data, and expertise in generating biological knowledge and join it with our partner’s pharmaceutical R&D expertise to accelerate the successful discovery and development of new therapies for significant unmet medical need, e.g., oncology, neurodegeneration, immunological, and cardiometabolic diseases.

BUILDING DEEP KNOWLEDGE OF COMPLEX HUMAN BIOLOGY TO DRIVE THE NEXT GENERATION OF BREAKTHROUGH THERAPIES

GENERATING NOVEL AND PRECISE UNDERSTANDINGS OF HUMAN DISEASE TO DRIVE PHARMACEUTICAL DISCOVERY AND DEVELOPMENT

NEW BIOLOGICAL KNOWLEDGE DRIVES FIRST-IN-CLASS AND BEST-IN-CLASS THERAPEUTICS

Our Team

WE ARE TRUE COLLABORATORS IN SHARING OUR KNOWLEDGE TO TRANSFORM DRUG DISCOVERY AND DEVELOPMENT

Join the Future of Biotech: Your Opportunity to Shape Tomorrow's Discoveries

Press Release

In the News

Events